Sale of Securities

Royalty Pharma plc Filed 2026-07-01 Acc 0001628280-26-046352

Documents 1

2026-07-02 4 EVP, Research & Investments sold 9,099 shares at $55.88 ($508,454)
2026-07-02 4 EVP & Chairman, Partnering sold 130,000 shares at an average $56.50 ($7,345,471)
2026-07-01 144 Sale of Securities
2026-07-01 144 Sale of Securities
2026-06-30 4 Director acquired 689 shares (grant or award)
2026-06-25 4 EVP, Research & Investments sold 9,098 shares at $55.18 ($502,067)
2026-06-24 144 Sale of Securities

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

Loading xsl144X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…